Kolmar BNH announced on the 18th that its second-quarter earnings were provisionally recorded at 128.7 billion won in sales and 10.5 billion won in operating profit. This represents increases of 1.8% and 27%, respectively, compared to the same period last year.
Compared to the first quarter of this year, sales increased by about 12% and operating profit increased by 191%. Kolmar BNH noted, "With stable sales flow, the profitability-focused restructuring is becoming a reality."
This improvement in performance was effective despite declines in sales from major clients, as the proportion of high-profit Original Design Manufacturing (ODM) for other clients expanded, along with a profitability-focused strategy in its own overseas business. In particular, the transfer of volumes to the powder and tablet-focused Sejong Plant 3 has stabilized the operating rate, contributing to improved profitability.
Kolmar BNH has set a performance target of 635 billion won in sales and 32 billion won in operating profit for this year. To achieve this, the company plans to focus on diversifying its client portfolio in the second half of the year.
A representative from Kolmar BNH said, "As the health functional food market is recovering and the expansion of the operating rate at Sejong Plant 3 is expected to alleviate fixed costs, achieving this year’s performance targets will not be a problem."